Fear of safety compromise with biosimilar anti-VEGF-perception or truth.
作者信息
Sharma Ashish, Parachuri Nikulaa, Kumar Nilesh, Bandello Francesco, Kuppermann Baruch D
机构信息
Lotus Eye Hospital and Institute, Avinashi Road, Coimbatore, TN, India.
Sankara Eye Hospital, Coimbatore, TN, India.
出版信息
Eye (Lond). 2022 Nov;36(11):2086-2087. doi: 10.1038/s41433-022-02117-z. Epub 2022 May 26.
Abstract
摘要
相似文献
1
Fear of safety compromise with biosimilar anti-VEGF-perception or truth.对生物类似药抗VEGF安全性受损的担忧——认知还是事实。
Eye (Lond). 2022 Nov;36(11):2086-2087. doi: 10.1038/s41433-022-02117-z. Epub 2022 May 26.
2
Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison.英夫利昔单抗生物类似药与其他生物药物治疗类风湿关节炎的疗效和安全性：一项混合治疗比较。
Eur J Health Econ. 2014 May;15 Suppl 1(Suppl 1):S53-64. doi: 10.1007/s10198-014-0594-4. Epub 2014 May 16.
3
[First biosimilar infliximab approved].首款生物类似药英夫利昔单抗获批。
MMW Fortschr Med. 2015 Mar 26;157 Suppl 1:88. doi: 10.1007/s15006-015-2875-y.
4
A review article on biosimilar infliximab SB2 in the treatment of rheumatoid arthritis.关于生物类似药 infliximab SB2 治疗类风湿关节炎的综述文章。
Immunotherapy. 2017 Nov;9(14):1133-1142. doi: 10.2217/imt-2017-0068. Epub 2017 Sep 18.
5
Comparative efficacy and safety of biosimilar rituximab and originator rituximab in combination with methotrexate in patients with active rheumatoid arthritis: A Bayesian network meta-analysis
.生物类似药利妥昔单抗与原研利妥昔单抗联合甲氨蝶呤治疗活动性类风湿关节炎患者的疗效和安全性比较：一项贝叶斯网络荟萃分析
Int J Clin Pharmacol Ther. 2019 Apr;57(4):188-196. doi: 10.5414/CP203360.
6
Infliximab Biosimilar (CT-P13; Infliximab-dyyb): A Review in Autoimmune Inflammatory Diseases.英夫利昔单抗生物类似药（CT-P13；英夫利昔单抗-dyyb）：在自身免疫性炎症性疾病中的应用评价。
BioDrugs. 2016 Oct;30(5):469-480. doi: 10.1007/s40259-016-0193-2.
7
Progress in biosimilar monoclonal antibody development: the infliximab biosimilar CT-P13 in the treatment of rheumatic diseases.生物类似单克隆抗体研发进展：英夫利昔单抗生物类似药CT-P13在风湿性疾病治疗中的应用
Immunotherapy. 2015;7(2):73-87. doi: 10.2217/imt.14.109.
8
The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis.用于治疗类风湿性关节炎的新型生物类似药的安全性。
Expert Opin Drug Saf. 2017 Mar;16(3):289-302. doi: 10.1080/14740338.2017.1273899. Epub 2017 Jan 10.
9
A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis.一项关于英夫利昔单抗生物类似药 CT-P13 在类风湿关节炎和强直性脊柱炎患者中药物生存、安全性和有效性的 5 年回顾性分析。
Clin Drug Investig. 2020 Jun;40(6):541-553. doi: 10.1007/s40261-020-00907-5.
10
Analysis of clinical trials of biosimilar infliximab (CT-P13) and comparison against historical clinical studies with the infliximab reference medicinal product.生物类似药英夫利昔单抗（CT-P13）的临床试验分析以及与英夫利昔单抗参比药品历史临床研究的比较。
Expert Rev Clin Immunol. 2015;11 Suppl 1:S15-24. doi: 10.1586/1744666X.2015.1090314.
本文引用的文献
1
Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes.生物类似药 SB11 与雷珠单抗对照治疗新生血管性年龄相关性黄斑变性：一年期 III 期随机临床试验结果。
Br J Ophthalmol. 2023 Mar;107(3):384-391. doi: 10.1136/bjophthalmol-2021-319637. Epub 2021 Oct 16.
2
Biotherapeutics and immunogenicity: ophthalmic perspective.生物疗法与免疫原性：眼科视角
Eye (Lond). 2019 Sep;33(9):1359-1361. doi: 10.1038/s41433-019-0434-y. Epub 2019 Apr 9.
3
Attitudes towards subsequent entry biologics/biosimilars: A survey of Canadian rheumatologists.对后续进入市场的生物制剂/生物类似药的态度：一项对加拿大风湿病学家的调查。
Clin Rheumatol. 2015 Aug;34(8):1427-33. doi: 10.1007/s10067-014-2835-4. Epub 2015 Jan 15.
4
Viewpoint: knowledge and viewpoints on biosimilar monoclonal antibodies among members of the European Crohn's and Colitis Organization.观点：欧洲克罗恩病和结肠炎组织成员对生物类似单克隆抗体的认识与观点
J Crohns Colitis. 2014 Nov;8(11):1548-50. doi: 10.1016/j.crohns.2014.06.007. Epub 2014 Jul 6.
5
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.雷珠单抗与维替泊芬治疗新生血管性年龄相关性黄斑变性的比较。
N Engl J Med. 2006 Oct 5;355(14):1432-44. doi: 10.1056/NEJMoa062655.
6
Ranibizumab for neovascular age-related macular degeneration.雷珠单抗用于治疗新生血管性年龄相关性黄斑变性。
N Engl J Med. 2006 Oct 5;355(14):1419-31. doi: 10.1056/NEJMoa054481.
Zotero 插件